GLOBE LIFE INC
GLNYSETrading Snapshot
- Day Range
- $180.17 – $182.85
- 52-Week Range
- $127.85 – $191.55
- Volume
- $2.34B
- Avg Volume
- $1.63B
- Shares Outstanding
- 77.6M
- Next Earnings
- Oct 8, 2026
Fundamentals Snapshot
- Annual Revenue
- $6.00B
- Last Q Revenue
- $1.60B
- P/E Ratio
- 11.6
- P/S Ratio
- 2.3x
- EPS (TTM)
- $15.06
- Dividend Yield
- 0.62%
Why Investors Own GL
- ✓High-growth profile — revenue up +26.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 36% gross margin and 27% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About GLOBE LIFE INC
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Sector Update: Financial Stocks Mixed Monday Afternoon
Financial stocks were mixed in Monday afternoon trading, with the NYSE Financial Index decreasing 0.
Globe Life Announces New Share Repurchase Authorization
Globe Life Inc. (NYSE:GL) announced a new authorization, effective August 15, 2026, to repurchase up to $2.5 billion of common stock in the future under the Company's existing share repurchase program. This authorization was approved by Globe Life's Board of Directors during its regular quarterly board meeting on August 5, 2026, and replaces any previous authorizations.
Aflac: Reliable Dividend Compounder, Premium Justified, But Meaningful Upside Unlikely
Aflac Misses Q2 EPS Estimates Despite Solid US Sales Growth
Aflac's Q2 adjusted EPS misses estimates as lower investment income and FX weigh, but U.S. sales, policy persistency and capital returns offer support.
MFC Q2 Earnings Beat on Asia Growth and Strong Insurance Sales
Manulife Financial posts double-digit core earnings growth as Asia and Global WAM momentum, stronger sales and lower credit loss charges lift Q2 results.
VOYA Q2 Earnings Miss on Weak Alternative Investment Results
Voya Financial's Q2 earnings fall short as weak alternative investments and severance costs offset fee growth and commercial momentum.